1. Incorporation of von Willebrand Factor Improves MELD-Na Based Prediction of Early Mortality on the Waiting List for Liver Transplantation. (2021) Authors: Pereyra, D.; Györi, G.; Rumpf, B.; Köditz, C.; Ortmayr, G.; Santol, J.; Berlakovic, G.; Starlinger, P. Journal: HPB Issue: Volume 23(2021)Supplement 1 Page Start: S102 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Influence of perioperative selective serotonin reuptake inhibitor therapy on postoperative outcome in patients undergoing liver resection. (September 2018) Authors: Rumpf, B.; Pereyra, D.; Jonas, P.; Assinger, A.; Brostjan, C.; Grünberger, T.; Starlinger, P. Journal: HPB Issue: Volume 20(2018)Supplement 2 Page Start: S447 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Overshooting neutrophil attraction by osteopontin inhibits liver regeneration after partial hepatectomy. (March 2019) Authors: Pereyra, D.; Michels, L.; Köditz, C.; Rumpf, B.; Fuxsteiner, J.; Santol, J.; Najarnia, S.; Gabbassova, S.; Finsterbusch, M.; Stift, J.; Brostjan, C.; Grünberger, T.; Assinger, A.; Starlinger, P. Journal: European journal of cancer Issue: Volume 110(2019)Supplement 1 Page Start: S33 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Perioperative use of selective serotonin reuptake inhibitors is associated to poor postoperative outcome in patients undergoing liver resection. (2020) Authors: Pereyra, D.; Rumpf, B.; Köditz, C.; Schütz, C.; Brostjan, C.; Grünberger, T.; Starlinger, P. Journal: HPB Issue: Volume 22(2020)Supplement 1 Page Start: S97 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Plasma Metabolomics in Liver Tumor Patients and its Predictive Performance for Postoperative Disease-free Survival Assessment. (2021) Authors: Jonas, P.; Pereyra, D.; Santol, J.; Rumpf, B.; Ortmayr, G.; Brostjan, C.; Grünberger, T.; Starlinger, P. Journal: HPB Issue: Volume 23(2021)Supplement 1 Page Start: S151 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Preoperative Serum Axl/Gas6 Allow Stratification of Oncological Outcome in Patients Undergoing Liver Resection for Hepatocellular Carcinoma. (2021) Authors: Gabbassova, S.; Pereyra, D.; Ortmayr, G.; Köditz, C.; Rumpf, B.; Santol, J.; Grünberger, T.; Mikulits, W.; Starlinger, P. Journal: HPB Issue: Volume 23(2021)Supplement 1 Page Start: S148 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Serum Axl/Gas6 Allows Prediction Of Oncological Outcome In Patients Suffering From Hepatocellular Carcinoma Undergoing Curative Liver Resection. (2020) Authors: Ortmayr, ; Pereyra, D.; Köditz, C.; Santol, J.; Rumpf, B.; Fuxsteiner, J.; Mikultis, W.; Starlinger, P. Journal: HPB Issue: Volume 22(2020)Supplement 1 Page Start: S29 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. The Ratio of Activin A and FLRG Allows Prediction of Postoperative Liver Dysfunction in Patients Undergoing Liver Resection. (2022) Authors: Santol, J.; Pereyra, D.; Hägele, S.; Ammon, D.; Ortmayr, G.; Jonas, J.P.; Rumpf, B.; Grünberger, T.; Starlinger, P. Journal: HPB Issue: Volume 24(2022)Supplement 1 Page Start: S222 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Validation of the APRI+ALBI smart phone application for preoperative risk assessment after liver resection in a routine clinical setting. (2021) Authors: Pereyra, D.; Santol, J.; Ammon, D.; Ortmayr, G.; Jonas, J.P.; Koeditz, C.; Rumpf, B.; Gruenberger, T.; Starlinger, Johannes; Smoot, R.L.; Cleary, S.P.; Starlinger, P. Journal: HPB Issue: Volume 23(2021)Supplement 2 Page Start: S666 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Von Willebrand factor antigen as a versatile preoperative marker in patients undergoing liver resection for hepatocellular carcinoma. (2021) Authors: Pereyra, D.; Mandorfer, M.; Santol, J.; Koeditz, C.; Ortmayr, G.; Schuetz, C.; Rumpf, B.; Laengle, J.; Jonas, P.; Tamandl, D.; Gruenberger, T.; Reiberger, T.; Cleary, S.P.; Starlinger, P. Journal: HPB Issue: Volume 23(2021)Supplement 2 Page Start: S494 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗